KKPCF Kaken Pharmaceutical Co., Ltd. Forecast, Technical & Fundamental Analysis

Momentum Indicator for KKPCF turns positive, indicating new upward trend

KKPCF saw its Momentum Indicator move above the 0 level on November 03, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator turned positive. In of the 7 cases, the stock moved higher in the following days. The odds of a move higher are at .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for KKPCF just turned positive on November 07, 2025. Looking at past instances where KKPCF's MACD turned positive, the stock continued to rise in of 9 cases over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

KKPCF moved below its 50-day moving average on October 20, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for KKPCF crossed bearishly below the 50-day moving average on October 20, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 6 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.948) is normal, around the industry mean (18.827). P/E Ratio (257.829) is within average values for comparable stocks, (71.764). KKPCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.856). Dividend Yield (0.047) settles around the average of (0.031) among similar stocks. P/S Ratio (1.722) is also within normal values, averaging (39.291).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. KKPCF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. KKPCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.